Bromantane
Sign in to saveBromantane, sold under the brand name Ladasten, is an atypical central nervous system (CNS) stimulant and anxiolytic drug of the adamantane family that is related to amantadine and memantine. Medically, it is approved in Russia for the treatment of neurasthenia. Although the effects of bromantane have been determined to be dependent on the dopaminergic and possibly serotonergic neurotransmitter systems, its exact mechanism of action is unknown, and is distinct in its properties relative to typical stimulants such as amphetamine. Bromantane has sometimes been described as an actoprotector (synt
Article
15 sectionsContents
- Effects
- Clinical research
- Psychotropic effects
- Pharmacology
- Pharmacodynamics
- Dopamine synthesis enhancement
- Monoamine reuptake inhibition
- Other actions
- Pharmacokinetics
- Chemistry
- Synthesis
- History
- See also
- References
- External links
Bromantane, sold under the brand name Ladasten, is an atypical central nervous system (CNS) stimulant and anxiolytic drug of the adamantane family that is related to amantadine and memantine. Medically, it is approved in Russia for the treatment of neurasthenia. Although the effects of bromantane have been determined to be dependent on the dopaminergic and possibly serotonergic neurotransmitter systems, its exact mechanism of action is unknown, and is distinct in its properties relative to typical stimulants such as amphetamine. Bromantane has sometimes been described as an actoprotector (synthetic adaptogen).
==Effects==
Connections
Categories
4-Bromophenyl compoundsAdamantanesAnilinesAntidepressantsAntiparkinsonian agentsAnxiolyticsAphrodisiacsChemical pages without DrugBank identifierDopamine reuptake inhibitorsDrugs in the Soviet UnionDrugs not assigned an ATC codeDrugs with non-standard legal statusDrugs with unknown mechanisms of action